<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04565444</url>
  </required_header>
  <id_info>
    <org_study_id>A11-M51-19A</org_study_id>
    <nct_id>NCT04565444</nct_id>
  </id_info>
  <brief_title>Ketones and Muscle Protein Synthesis</brief_title>
  <official_title>The Effects of Acute Nutritional Ketosis on Myofibrillar Protein Synthesis in Young Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ketones are natural substances normally produced by the body during prolonged fasting and&#xD;
      starvation, or in response to a &quot;ketogenic&quot; diet to be used as fuel by the brain and muscles.&#xD;
      Ketones are therefore similar to dietary proteins, carbohydrates and fats since they&#xD;
      represent a source of energy for the body. In addition to serving as a source of energy,&#xD;
      ketones have also been shown to stimulate increased rates of muscle protein synthesis in&#xD;
      humans.&#xD;
&#xD;
      The ingestion of dietary protein is well established to stimulate an increase in the rate of&#xD;
      protein synthesis in skeletal muscle. The rate of muscle protein synthesis can be maximized&#xD;
      following the intake of 20g of protein. As a result, smaller doses of protein (i.e. 10g)&#xD;
      represent a sub-optimal dose of protein because there is still room for improvement&#xD;
      concerning muscle protein synthesis.&#xD;
&#xD;
      Recently ketone-containing food products have become available that elevate ketone levels in&#xD;
      the body without the need for ketogenic diets or prolonged fasting. Therefore, the purpose of&#xD;
      this study is to measure skeletal muscle protein synthesis rates after ingesting the&#xD;
      following:&#xD;
&#xD;
        1. Ketone monoester&#xD;
&#xD;
        2. Ketone monoester supplemented with sub-optimal dose of whey protein&#xD;
&#xD;
        3. Sub-optimal dose of whey protein&#xD;
&#xD;
      It is hypothesized that muscle protein synthesis rates will increase following the ingestion&#xD;
      of a ketone-containing beverage. Further, muscle protein synthesis rates will be enhanced&#xD;
      when the ketone-containing beverage and sub-optimal protein dose are taken together.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Actual">May 14, 2021</completion_date>
  <primary_completion_date type="Actual">May 14, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fractional synthetic rate of muscle protein synthesis (myofibrillar)</measure>
    <time_frame>0-5 hours in the post-prandial period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fractional synthetic rate of muscle protein synthesis (myofibrillar)</measure>
    <time_frame>0-3 hours in the pre-prandial period; 0-2 hours, and 2-5 hours into the post-prandial period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma enrichments (in moles percent excess) of L-[ring-2H5]-phenylalanine</measure>
    <time_frame>3 hours pre-prandial to 5 hours post-prandial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose concentration (mmol/L)</measure>
    <time_frame>3 hours pre-prandial to 5 hours post-prandial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma insulin concentration (pmol/L)</measure>
    <time_frame>3 hours pre-prandial to 5 hours post-prandial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma amino acid concentrations (mmol/L)</measure>
    <time_frame>3 hours pre-prandial to 5 hours post-prandial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Capillary blood Beta-OHB concentrations (mmol/L)</measure>
    <time_frame>0-5 hours in the post-prandial period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Signaling molecule phosphorylation status</measure>
    <time_frame>0, 2, and 5 hours into the post-prandial period</time_frame>
    <description>The use of Western blots to measure the phosphorylation status of signaling molecules involved in protein synthesis ie. mTOR, p70S6k, 4E-BP1</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Ketosis</condition>
  <condition>Regulation of Muscle Protein Synthesis</condition>
  <arm_group>
    <arm_group_label>Ketone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and carbohydrate control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketone + Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and 10g of whey protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Carbohydrate control and 10g of whey protein.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ketone</intervention_name>
    <description>Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight)&#xD;
Isocaloric carbohydrate control: dextrose + vanilla flavouring</description>
    <arm_group_label>Ketone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ketone + Protein</intervention_name>
    <description>Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight)&#xD;
10g Whey Protein&#xD;
L-[ring-2H5]-phenylalanine tracer (enriched to 4%)</description>
    <arm_group_label>Ketone + Protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein</intervention_name>
    <description>Isocaloric carbohydrate control: dextrose + stevia&#xD;
10g Whey Protein&#xD;
L-[ring-2H5]-phenylalanine tracer (enriched to 4%)</description>
    <arm_group_label>Protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Aged between 18-35 years inclusive&#xD;
&#xD;
          -  Healthy, moderately active&#xD;
&#xD;
          -  BMI &lt; 30 kg/m2 and &gt; 18.5 kg/m2&#xD;
&#xD;
          -  Having given informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of any identified metabolic or intestinal disorders&#xD;
&#xD;
          -  Use of tobacco products&#xD;
&#xD;
          -  Allergies to milk proteins (whey or casein)&#xD;
&#xD;
          -  Lactose intolerance&#xD;
&#xD;
          -  Phenylketonuria (PKU)&#xD;
&#xD;
          -  A history of neuromuscular problems&#xD;
&#xD;
          -  Previous participation in amino acid tracer studies&#xD;
&#xD;
          -  Adherence to a strict vegetarian or vegan diet&#xD;
&#xD;
          -  Current use of ketone supplements or adherence to a ketogenic diet&#xD;
&#xD;
          -  Use of medications known to affect protein metabolism&#xD;
&#xD;
          -  Diagnosis of Diabetes&#xD;
&#xD;
          -  Engagement in sports or physical exercise 5 or more days per week&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tyler A Churchward-Venne, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Exercise Metabolism and Nutrition Research Laboratory</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1S4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>September 17, 2020</study_first_submitted>
  <study_first_submitted_qc>September 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2020</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University</investigator_affiliation>
    <investigator_full_name>Tyler Churchward-Venne</investigator_full_name>
    <investigator_title>Tyler A. Churchward-Venne, Ph.D., Assistant Professor, McGill University</investigator_title>
  </responsible_party>
  <keyword>ketone</keyword>
  <keyword>protein metabolism</keyword>
  <keyword>muscle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

